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Background: Arteriogenesis is a potent natural defense mechanism that protects the myocardium from ischemic damage in patients with a 
coronary artery disease. Monocytes/macrophages are known to be important modulators of this process. In the present study, we investigated the 
transcriptome of the circulating monocytes of patients with a total coronary occlusion to find targets that are important for arteriogenesis.
Methods: A total of 50 patients with a chronic total coronary occlusion were dichotomized according to their collateral flow index (CFI), which 
is the golden standard to measure the capacity of the collateral circulation. From each patient, RNA was isolated from unstimulated peripheral 
blood monocytes, monocytes stimulated by lipopolysaccharide (LPS), or from monocytes after differentiation into macrophages. Whole genome 
transcriptome analysis was performed in carefully matched patients from both ends of the CFI spectrum and analysed by pathway-based 
bioinformatics. The expression of genes of interest was validated using RT-PCR. Galectin-2 intron 1 3279C>T was typed by HpyCH4IV digestion of PCR 
products.
Results: Genome-wide mRNA expression analysis confirmed our previous findings of enhanced Interferon-beta signaling in patients with low CFI. 
Interestingly, increased expression of Galectin-2 was observed in all three cell types from patients with low CFI, as compared to the patients with 
high CFI. This observation could be confirmed by RT-PCR (p=0.01 for the resting monocytes; p= 0.05 for the LPS stimulated monocytes; p=0.02 
for the macrophages). In vitro effects of Galectin-2 on several cell types involved in arteriogenesis were studied. Importantly, we found that the 
expression of Galectin-2 was associated with the Galectin-2 intron 1 3279C>T single nucleotide polymorphism (SNP), a transcriptional regulatory 
SNP that has previously been reported to be associated with myocardial infarction. 
Conclusions: The results of the present study suggest that Galectin-2 and the Galectin-2 intron 1 SNP, as a regulator of Galectin-2 expression, 
have an important role in arteriogenesis
